Cargando…

Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Pulmonary arterial hypertension (PAH) is a destructive and rare disorder characterized by a progressive increase in pulmonary artery pressure and vasoconstriction, ultimately leading to right ventricular failure and death. 18β-Glycyrrhetinic acid (18β-GA) is an active ingredient in the commonly used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Min, Chang, Zhi, Zhao, Fang, Zhang, Peng, Hao, Yin-Ju, Yan, Lin, Liu, Ning, Wang, Jun-Li, Bo, Lei, Ma, Ping, Zhou, Wei, Ma, Xuan, Xu, Qing-Bin, Zhou, Ru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349717/ https://www.ncbi.nlm.nih.gov/pubmed/30723409 http://dx.doi.org/10.3389/fphar.2019.00013

Ejemplares similares

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Naringin Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension Through Endothelial-To-Mesenchymal Transition Inhibition
por: Wu, Yonghui, et al.
Publicado: (2021)

Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition
por: Chen, Xing, et al.
Publicado: (2022)

Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019)

Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats
por: IMOTO, Keisuke, et al.
Publicado: (2017)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
por: Ding, Mingge, et al.
Publicado: (2015)

Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response
por: Yang, Jia-mei, et al.
Publicado: (2018)

Protective effect of hydrogen sulfide on monocrotaline-induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition
por: Zhang, Hui, et al.
Publicado: (2019)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

Astragaloside IV blocks monocrotaline-induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling
por: Jin, Haifeng, et al.
Publicado: (2021)

Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats
por: Han, Xiaotong, et al.
Publicado: (2016)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)

Glycyrrhetinic Acid Maintains Intestinal Homeostasis via HuR
por: Chen, Gang, et al.
Publicado: (2019)

Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome
por: Deng, Yan, et al.
Publicado: (2019)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
por: Wang, Zhangting, et al.
Publicado: (2022)

Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline
por: Qin, Tianyou, et al.
Publicado: (2022)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis
por: Yan, Miao, et al.
Publicado: (2021)

Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020)

Protective Effect of Triclosan in Monocrotaline-Induced Pulmonary Arterial Hypertension: FASN Inhibition a Novel Approach
por: Alsabeelah, Nimer, et al.
Publicado: (2022)

Protective Effect of 18β-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats
por: Yang, Guanghua, et al.
Publicado: (2017)

Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
por: Cai, Changhong, et al.
Publicado: (2019)

Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
por: Kim, Hae Jin, et al.
Publicado: (2016)

Nicorandil Attenuates Monocrotaline-Induced Vascular Endothelial Damage and Pulmonary Arterial Hypertension
por: Sahara, Makoto, et al.
Publicado: (2012)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats: Erratum
Publicado: (2015)

Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
por: Cheng, Yusheng, et al.
Publicado: (2018)

Anti-inflammatory and Pro-apoptotic Effects of 18beta-Glycyrrhetinic Acid In Vitro and In Vivo Models of Rheumatoid Arthritis
por: Feng, Yunhui, et al.
Publicado: (2021)

Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model
por: Wang, Yun, et al.
Publicado: (2011)

18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
por: Chen, Xiao, et al.
Publicado: (2018)

Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline
por: Zheng, Hai-Kuo, et al.
Publicado: (2018)

Effects of the peripheral CB(1) receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
por: Remiszewski, Patryk, et al.
Publicado: (2022)

Glycyrrhetinic Acid Protects Renal Tubular Cells against Oxidative Injury via Reciprocal Regulation of JNK-Connexin 43-Thioredoxin 1 Signaling
por: Zhou, Yao, et al.
Publicado: (2021)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
por: Polonio, Igor Bastos, et al.
Publicado: (2014)

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
por: Li, Huayang, et al.
Publicado: (2021)

Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia
por: Zhang, Tingting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_12l39btn5m76qca4d138t6j9ro